Qualigen Therapeutics Initiates Good Laboratory Practice (GLP) Toxicology Studies on QN-302
24 janv. 2023 09h00 HE
|
Qualigen Therapeutics, Inc.
CARLSBAD, Calif., Jan. 24, 2023 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (“Qualigen” or “the Company,” Nasdaq: QLGN), a diversified life sciences company focused on developing treatments for...